Document is current

Article History

Received: 26 June 2021

Accepted: 11 October 2021

First Online: 16 October 2021

Compliance with ethical standards

:

: Kazuhiro Yoshida has received research funding from Asahi Kasei Co., Ltd., Chugai Pharmaceutical Co., Ltd., Covidien Japan, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Eli Lilly Japan K.K., Johnson & Johnson K.K., Merck Serono Co., Ltd., MSD K.K., Nippon Kayaku Co., Ltd., Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Sanofi K.K., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Tsumura & Co., Yakult Honsha Co. Ltd., Abbott Japan Co., Ltd., AbbVie GK, Astellas Pharma Inc., Biogen Japan Ltd., Celgene Corporation, GlaxoSmithKline K.K., KCI, Koninklijke Philips N.V., Kyouwa Hakkou Kirin Co., Ltd., Meiji Seika Pharma Co., Ltd., Toray Medical Co., Ltd., Kaken Pharmaceutical Co., Ltd.; honoraria from Asahi Kasei Co., Ltd., Chugai Pharmaceutical Co., Ltd., Covidien Japan, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Eli Lilly Japan K.K., Johnson & Johnson K.K., Merck Serono Co., Ltd., MSD K.K., Nippon Kayaku Co., Ltd., Novartis Pharma K.K., Ono Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Sanofi K.K., Taiho Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Tsumura & Co., Yakult Honsha Co., Ltd., AstraZeneca K.K., Bristol-Myers Squibb., Denka Company Limited, EA Pharma Co., Ltd., Olympus Corporation., Pfizer Japan Inc., Sanwa Kagaku Kenkyusho Co., Ltd., SBI Pharmaceuticals Co., Ltd., Teijin Pharma Limited, Terumo Corporation; and others from Yakult Honsha Co., Ltd. (no involvement in intellectual property) outside the submitted work. Yoshihiro Tanaka and the other co-authors declare that they have no conflicts of interest of declare.

: Not applicable.

: Written informed consent was obtained from the patient for the publication of this case report and accompanying images.